How effective is Meloxicam for Localised Osteoarthritis? (a real world drug study)

Summary:

Overall ratings: 3.3/5
Long term ratings: 2/5

This is a phase IV clinical study of how effective Meloxicam (meloxicam) is for Localised osteoarthritis and for what kind of people. The study is created by eHealthMe from 3 Meloxicam users and is updated continuously.

What is Meloxicam?

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 68,017 Meloxicam users. Check the latest studies of Meloxicam.

What is Localised osteoarthritis?

Localised osteoarthritis (infection of joint affects only single joint) is found to be associated with 99 drugs and 125 conditions by eHealthMe. Check the latest studies of Localised osteoarthritis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.


On Sep, 02, 2026

3 people are studied for taking Meloxicam in Localised osteoarthritis

Overall effectiveness (number of people):

Does Meloxicam work for your Localised osteoarthritis (overall)?

Long term (1+ years) effectiveness (number of people):

Does Meloxicam work for your Localised osteoarthritis (long term)?

Meloxicam effectiveness for Localised osteoarthritis (number of people):

Overall:
  • not at all: 0
  • somewhat: 1
  • moderate: 1
  • high: 0
  • very high: 1
Long Term:
  • not at all: 0
  • somewhat: 1
  • moderate: 0
  • high: 0
  • very high: 0

Gender of people who take Meloxicam for Localised osteoarthritis *:

  • female: 100 %
  • male: 0.0 %

Age of people who take Meloxicam for Localised osteoarthritis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 66.67 %
  • 60+: 33.33 %

Who find Meloxicam more effective for Localised Osteoarthritis?

Gender of people who take Meloxicam for Localised osteoarthritis *:

  • female: 100 %
  • male: 0.0 %

Age of people who take Meloxicam for Localised osteoarthritis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

* Approximation only. Some reports may have incomplete information.

Do you take Meloxicam?

- You can start a phase IV clinical trial to monitor Meloxicam safety and effectiveness.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on meloxicam (the active ingredients of Meloxicam) and Meloxicam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: